A) Enzyme replacement therapy
B) Periodic infusion of genetically engineered lymphocytes having functional ADA cDNA
C) Administering adenosine deaminase activators
D) Introducing bone marrow cells producing ADA into cells at early embryonic stages
Correct Answer: D
Solution :
By introducing bone marrow cells producing ADA into cells in early embryonic stages, the genetic defect adenosine deaminase (ADA) deficiency may be cured permanently. It is due to mutation.
You need to login to perform this action.
You will be redirected in
3 sec
